Incidence of solid tumors in polycythemia vera treated with phlebotomy with or without hydroxyurea: ECLAP follow-up data

Polycythemia vera and essential thrombocythemia: 2017 update on diagnosis, risk-stratification, and management

(2016) Ayalew Tefferi et al.   AMERICAN JOURNAL OF HEMATOLOGY

Risk and Cause of Death in Patients Diagnosed With Myeloproliferative Neoplasms in Sweden Between 1973 and 2005: A Population-Based Study

(2015) Malin Hultcrantz et al.   JOURNAL OF CLINICAL ONCOLOGY

Secondary solid tumors and lymphoma in patients with essential thrombocythemia and polycythemia vera – single center experience

(2015) Lucia Masarova et al.   LEUKEMIA & LYMPHOMA

Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study

(2013) A Tefferi et al.   LEUKEMIA

Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials

(2012) Annemijn M Algra et al.   LANCET ONCOLOGY

Chronic myeloproliferative neoplasms and subsequent cancer risk: a Danish population-based cohort study

(2011) H. Frederiksen et al.   BLOOD

Higher risk of primary cancers after polycythaemia vera and vice versa

(2011) Mahdi Fallah et al.   BRITISH JOURNAL OF HAEMATOLOGY

Philadelphia-Negative Classical Myeloproliferative Neoplasms: Critical Concepts and Management Recommendations From European LeukemiaNet

(2011) Tiziano Barbui et al.   JOURNAL OF CLINICAL ONCOLOGY

An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies

(2011) Peter C. Austin   MULTIVARIATE BEHAVIORAL RESEARCH

Increased Risk of Lymphoid Neoplasms in Patients with Philadelphia Chromosome-Negative Myeloproliferative Neoplasms

(2009) A. M. Vannucchi et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION